Holen Sie sich die Stockscreener-App
3.4501
4.52%
0.1301
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.32
Offen:
$3.35
24-Stunden-Volumen:
33,806
Relative Volume:
0.17
Marktkapitalisierung:
$9.56M
Einnahmen:
$36.12M
Nettoeinkommen (Verlust:
$-232.49M
KGV:
-0.194
EPS:
-17.78
Netto-Cashflow:
$-126.87M
1W Leistung:
-14.95%
1M Leistung:
-39.76%
6M Leistung:
-86.56%
1J Leistung:
-94.33%
1-Tages-Spanne:
$3.33
$3.50
1-Wochen-Bereich:
$3.30
$4.17
52-Wochen-Spanne:
$3.30
$72.60
Bionano Genomics Inc Stock (BNGO) Company Profile
Firmenname
Bionano Genomics Inc
Sektor
Telefon
(858) 888-7600
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Vergleichen Sie BNGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
3.46 | 9.56M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
490.26 | 173.48B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
225.09 | 64.38B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
88.20 | 43.42B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
223.37 | 32.44B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.84 | 17.68B | 17.28B | 108.00M | 391.00M | 0.20 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-12 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-06-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-24 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-04-08 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - TradingView
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML - The Manila Times
Bionano Genomics to Host Webinar on Study Revealing Optical Genome Mapping's Role in Acute Myeloid Leukemia Detection - Nasdaq
Major Cancer Breakthrough: New Technology Identifies Hidden AML Risk Factor Linked to 66% Lower Survival Rate - StockTitan
BNGO stock touches 52-week low at $3.73 amid market challenges By Investing.com - Investing.com South Africa
BNGO stock touches 52-week low at $3.73 amid market challenges - Investing.com UK
Bionano Genomics (BNGO) to Release Earnings on Wednesday - Defense World
Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView
Bionano Genomics (BNGO) Expected to Announce Earnings on Tuesday - Defense World
BNGO stock touches 52-week low at $4.75 amid market challenges - Investing.com Australia
BNGO stock touches 52-week low at $4.75 amid market challenges By Investing.com - Investing.com South Africa
When the Price of (BNGO) Talks, People Listen - Stock Traders Daily
BioNano Genomics Executes Significant Reverse Stock Split - MSN
Bionano Genomics announces 1-for-60 reverse stock split - MSN
Bionano Genomics ends sales agreement with Cowen - MSN
Slammed 62% Bionano Genomics, Inc. (NASDAQ:BNGO) Screens Well Here But There Might Be A Catch - Simply Wall St
Bionano Genomics ends sales agreement with Cowen By Investing.com - Investing.com South Africa
BioNano Genomics Ends Sales Agreement with Cowen - TipRanks
Bionano Genomics IncOn February 4, Terminates Sales Agreement With Cowen Effective February 14, 2025 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline - MSN
Bionano Announces Effective Date of Reverse Stock Split - EIN News
Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline By Investing.com - Investing.com South Africa
Bionano Genomics, Inc. (NASDAQ:BNGO) Sees Large Decrease in Short Interest - MarketBeat
Bionano Genomics (NASDAQ:BNGO) Stock Price Up 5.5%Time to Buy? - MarketBeat
Page 16 | BIONANO GENOM. CP DL-0001 Trade Ideas — BER:2Y3 - TradingView
Bionano Genomics (NASDAQ:BNGO) Shares Gap DownWhat's Next? - MarketBeat
Bionano Genomics (NASDAQ:BNGO) Hits New 52-Week LowHere's Why - MarketBeat
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges - MSN
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges By Investing.com - Investing.com South Africa
Bionano Genomics stock slips on reverse stock split (BNGO) - Seeking Alpha
Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News - StockTitan
Bionano Genomics shareholders approve stock issuance and reverse split - Investing.com India
Bionano Genomics shareholders approve stock issuance and reverse split By Investing.com - Investing.com UK
Bionano Genomics, Inc. Announces Use of Ogm in Preimplantation Genetic Testing as Part of Successful Live Birth to A Couple Experiencing Recurrent Pregnancy Loss - Marketscreener.com
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss - The Manila Times
Bionano's Genome Mapping Tech Enables Breakthrough in IVF Success After Recurrent Pregnancy Loss - StockTitan
Bionano reports Q4 preliminary revenue in range of $7.9 million to $8.1 million - MSN
Bionano Genomics, Inc. Provides Earnings Guidance for the Fourth Quarter and for Full Year 2024 - Marketscreener.com
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - The Manila Times
Bionano Genomics, Inc. (NASDAQ:BNGO) Position Raised by Geode Capital Management LLC - Defense World
Bionano Q4 Revenue Dips 25% YoY But Shows Strong Sequential Growth, OGM System Base Expands 14% - StockTitan
Bionano Genomics Announces $10 Million Registered Direct OfferingOn January 3, 2025, Bionano Genomics, Inc. (NASDAQ: BNGO) disclosed a definitive agreement with institutional investors for a registered direct offering. The offering involves the purch - Defense World
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.00%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):